Picture of Oramed Pharmaceuticals logo

ORMP Oramed Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Oramed Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
August 31st
2021
August 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments39.994.1156162142
Prepaid Expenses
Total Current Assets40.595.3157163143
Net Property, Plant And Equipment0.1740.931.81.571.11
Long Term Investments
Other Long Term Assets
Total Assets44.6128162221155
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities4.546.685.7553.25.68
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities11.812.29.8356.79.01
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity32.9116152164146
Total Liabilities & Shareholders' Equity44.6128162221155
Total Common Shares Outstanding